Where I see patients (5)
Selected research
-
Subsequent Renal Cancer Among Childhood Cancer Survivors: Analysis of Surveillance, Epidemiology, and End Results.
Journal of pediatric hematology/oncology
-
Consensus classification of pediatric hepatocellular tumors: A report from the Children's Hepatic tumors International Collaboration (CHIC).
Pediatric blood & cancer
-
Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children's Hepatic Tumors International Collaboration (CHIC).
Cancers
Clinical trials
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarco...
Estimated four year thoracic event free survival (tEFS) where tEFS is calculated as the time from study enrollment. Any recurrence within the pulmonary parenchyma, involving the pleural surface or the drain/surgical site wound wil...
Recruiting
More about this studyChemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusi...
The Kaplan-Meier method will be used to estimate 3-year FFS along with 80% log-minus-log transformed confidence limits for very low risk (VLR) patients.
Recruiting
More about this studyProject: Every Child for Younger Patients With Cancer
The number of patients who agree to be in the Biobanking part of the study and have leftover tumor tissue and some normal blood, bone marrow, or other tissue saved for future research.
Recruiting
More about this studyTargeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Adva...
Will be estimated over time and considered in relationship to changes in treatment trial cohort status (activations, suspensions, terminations).
Recruiting
More about this studyET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinom...
Safety of ET140203 T cells as assessed by the number of adverse events (AEs) after infusion
Recruiting
More about this studyTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Re...
Response rates will be calculated as the percent of evaluable patients who are responders, and confidence intervals will be constructed using the Wilson score interval method.
Recruiting
More about this studyA Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
For Strata 1-3, the primary analysis of EFS will consist of a one-sample, one-sided log rank test versus a historical control cohort (or representative distribution) with stratum-specific type I error levels. For Stratum 4, the pr...
Recruiting
More about this studyActive Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and A...
The time from study entry to the date of death, or date of last contact and ascertained as alive, whichever comes first.
Recruiting
More about this studyCheckpoint Inhibition In Pediatric Hepatocellular Carcinoma
irRECIST criteria
Recruiting
More about this studyEnsartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin ...
A responder is defined as a patient who achieves a best response of partial response or complete response on the study. Response rates will be calculated as the percent of evaluable patients who are responders, and confidence inte...
Recruiting
More about this studyContact me
Translation, please
We have interpreters for Cantonese, Mandarin, Spanish, Russian, American Sign Language and more.
Request an interpreter![](/-/media/project/ucsf/ucsf-bch/images/by-your-side-moment/duck/bys_footer_duck-playful-2x.jpg?rev=1202c0da42924c018f0aa29874303fe9&hash=EA0B683476A8641ABA67D2564291622E)